Lipase Inhibitor, THL CAS: 96829-58-2
MF: C29H53NO5
MW: 495.7
An inhibitor of pancreatic and gastric lipase, and an activator of caspase-3..

Lipase Inhibitor, THL (CAS 96829-58-2)

Lipase Inhibitor, THL | CAS 96829-58-2 is rated 5.0 out of 5 by 1.
  • y_2023, m_1, d_29, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.34
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203108, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 102ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Alternate Names: (-)-Tetrahydrolipstatin; Orlistat
Application: Lipase Inhibitor, THL is an inhibitor of pancreatic and gastric lipase, and an activator of caspase-3.
CAS Number: 96829-58-2
Purity: ≥98%
Molecular Weight: 495.7
Molecular Formula: C29H53NO5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

Lipase Inhibitor, THL (Tetrahydrolipstatin), is a compound that has been shown to rapidly inactivate lipoprotein lipase (LPL). This agent has been found to bind both subunits of LPL, induce tetramerisation, and cause local conformational changes. The exception to lipase inhibition capacities of THL is phospholipase A2, which is not affected by THL. Mechanistic studies suggest that THL inhibits the thioesterase domain of fatty acid synthase (FAS) and as a result halts cell proliferation and causes cell apoptosis. More detailed experiments show that gradually THL affects the retinoblastoma protein pathway and leads to cell-cycle arrest at G1/S boundary. Lipase Inhibitor, THL is an inhibitor of pancreatic and gastric lipase, as well as carboxyl ester lipase (CEL) and diacylglycerol lipase-α (DAGLα). Lipase Inhibitor, THL also activates caspase-3.


References

1. Lookene, A., et al. 1994. Eur. J. Biochem. 222: 395-403. PMID: 8020477
2. Sternby, B., et al. 2002. Clin Nutr. 21: 395-402. PMID: 12381337
3. Kridel, S.J., et al. 2004. Cancer Res. 64: 2070-2075. PMID: 15026345
4. Knowles, L.M., et al. 2004. J. Biol. Chem. 279: 30540-30545. PMID: 15138278

Physical State :
Solid
Solubility :
Soluble in DMSO (19 mg/mL), ethanol (20 mg/mL), and DMF (20 mg/mL).
Storage :
Store at -20° C
Melting Point :
<50° C
Boiling Point :
615.88° C at 760 mmHg (Predicted)
Refractive Index :
n20D 1.47
Optical Activity :
α20/D -35°, c = 1 in chloroform; α20/D°
IC50 :
LDL-associated phospholipase A2: IC50 = 50 nM (human); Sn1-specific diacylglycerol lipase beta: IC50 = 60 nM (human); Cannabinoid CB1 receptor: IC50 = 100 nM (rat); Pancreatic triacylglycerol lipase: IC50 = 600 nM (Sus scrofa); Protein BAT5: IC50 = 30 nM (human); Monoacylglycerol lipase ABHD12: IC50 = 80 nM (human)
Ki Data :
Cannabinoid CB1 receptor: Ki= 2500 nM (human); Cannabinoid CB2 receptor: Ki= >10000 nM (human)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
OH3167600
PubChem CID :
Merck Index :
14: 6869
MDL Number :
MFCD05662360
Beilstein Registry :
3658031
SMILES :
CCCCCCCCCCC[[email protected]@H](C[[email protected]]1[[email protected]@H](C(=O)O1)CCCCCC)OC(=O)[[email protected]](CC(C)C)NC=O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Lipase Inhibitor, THL (CAS 96829-58-2)  Product Citations

See how others have used Lipase Inhibitor, THL (CAS 96829-58-2). Click on the entry to view the PubMed entry .

Citations 1 to 7 of 7 total

PMID: 34311079 | Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis. | Manupati, K. et al. 2021. Biochim Biophys Acta Mol Basis Dis. 1867: 166228.

PMID: 29281779 |  | Mol. Cells. 935-944.

Citations 1 to 7 of 7 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 97ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Malvi Malvi, P. et al. (PubMed 25499031) found that Orlistat, an inhibitor of pancreatic and gastric lipase, and an activator of caspase-3, treatment and dietary intervention reversed rapid melanoma progression induced by obesity. -SCBT Publication Review
Date published: 2015-01-03
  • y_2023, m_1, d_29, h_21
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.34
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203108, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 21ms
  • REVIEWS, PRODUCT